KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Asset Writedowns and Impairment (2019 - 2024)

Twist Bioscience (TWST) has disclosed Asset Writedowns and Impairment for 6 consecutive years, with $293000.0 as the latest value for Q3 2024.

  • Quarterly Asset Writedowns and Impairment fell 80.89% to $293000.0 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $940000.0 through Sep 2024, down 63.47% year-over-year, with the annual reading at -$20000.0 for FY2025, 102.13% down from the prior year.
  • Asset Writedowns and Impairment for Q3 2024 was $293000.0 at Twist Bioscience, up from $144000.0 in the prior quarter.
  • The five-year high for Asset Writedowns and Impairment was $17.5 million in Q3 2022, with the low at -$1.0 million in Q3 2020.
  • Average Asset Writedowns and Impairment over 5 years is $1.3 million, with a median of $293000.0 recorded in 2024.
  • The sharpest move saw Asset Writedowns and Impairment soared 1379.41% in 2022, then crashed 91.26% in 2023.
  • Over 5 years, Asset Writedowns and Impairment stood at $248000.0 in 2020, then surged by 373.39% to $1.2 million in 2021, then tumbled by 78.36% to $254000.0 in 2022, then decreased by 2.36% to $248000.0 in 2023, then increased by 18.15% to $293000.0 in 2024.
  • According to Business Quant data, Asset Writedowns and Impairment over the past three periods came in at $293000.0, $144000.0, and $255000.0 for Q3 2024, Q2 2024, and Q1 2024 respectively.